These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15050732)

  • 1. Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol.
    Pourgholami MH; Lu Y; Wang L; Stephens RW; Morris DL
    Cancer Lett; 2004 Apr; 207(1):37-47. PubMed ID: 15050732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma.
    Morris DL; Jourdan JL; Finlay I; Gruenberger T; The MP; Pourgholami MH
    Int J Oncol; 2002 Oct; 21(4):901-6. PubMed ID: 12239633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
    Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
    Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z; Akhter J; Pourgholami MH; Morris DL
    Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose.
    Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A
    Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2.
    Pourgholami MH; Akhter J; Finlay IG; Morris DL
    Anticancer Res; 2000; 20(2A):723-7. PubMed ID: 10810346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Miyauchi Y; Funaki T; Yoneyama H; Miyoshi H; Yoshida S; Himoto T; Morishita A; Uchida N; Watanabe S; Kuriyama S
    Int J Oncol; 2004 Feb; 24(2):381-7. PubMed ID: 14719115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of iodinated fatty acid ester on human hepatocellular carcinoma cells.
    Kim H; Park C; Lee YB; Yoo HS; Park JH; Lee WY
    Yonsei Med J; 1991 Mar; 32(1):16-23. PubMed ID: 1652177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
    Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
    Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver cancer cells and endothelial cells incorporate iodised oil.
    Bhattacharya S; Dhillon AP; Winslet MC; Davidson BR; Shukla N; Gupta SD; Al-Mufti R; Hobbs KE
    Br J Cancer; 1996 Apr; 73(7):877-81. PubMed ID: 8611399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
    Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipiodol ultra-fluid: an antitumor agent-in vitro study.
    Durand-Fontanier S; Simon A; Duroux JL; Descottes B; Delage C
    Anticancer Res; 1999; 19(5B):4357-61. PubMed ID: 10628401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.